Skip to content

NCEL

NewCelX Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.15
−6.80%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
2.34x
Price / sales
Price / cash flow
-8.17x

Enterprise value

Enterprise value
$15.1M
EV / sales
EV / EBITDA
-4.70x
EV / EBIT
-2.57x
Market cap
$17.0M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026